Phase I-II Trial of Depsipeptide in Patients With Recurrent High-Grade Gliomas.
Latest Information Update: 06 Jan 2017
At a glance
- Drugs Romidepsin (Primary)
- Indications Glioma
- Focus Adverse reactions; Therapeutic Use
- 04 May 2012 Actual end date changed from Dec 2008 to Mar 2009 as reported by ClinicalTrials.gov.
- 04 May 2012 Actual end date changed from Dec 2008 to Mar 2009 as reported by ClinicalTrials.gov.
- 28 Dec 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.